XML 80 R63.htm IDEA: XBRL DOCUMENT v2.4.0.6
Stock-Based Compensation - Non-option Instruments (Details) (USD $)
In Millions, except Share data, unless otherwise specified
12 Months Ended
Jun. 02, 2012
Y
May 28, 2011
Y
May 29, 2010
Y
May 30, 2009
Y
Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Nonvested, Weighted Average Grant Date Fair Value [Roll Forward]        
Employee Service Share-based Compensation, Nonvested Awards, Total Compensation Cost Not yet Recognized, Period for Recognition 1.56      
Performance share units [Member]
       
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]        
Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Nonvested, Total Intrinsic Value $ 0 $ 0 $ 0 $ 0
Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Nonvested [Roll Forward]        
Outstanding, at beginning of year, Shares 90,380 178,862 182,977  
Granted, Shares 0 0 0  
Vested, Shares (90,380) (88,482) (4,115)  
Outstanding, at end of year, Shares 0 90,380 178,862 182,977
Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Nonvested, Weighted Average Grant Date Fair Value [Roll Forward]        
Outstanding, at beginning of year, Weighted Average Remaining Contractual Term (in years) 0.0 0.2 0.7 1.7
Outstanding, at end of year, Weighted Average Remaining Contractual Term (in years) 0.0 0.2 0.7 1.7
Ending vested and expected to vest, Shares 0 0 0  
Ending vested and expected to vest, Aggregrate Intrinsic Value (in dollars) 0 0 0  
Ending vested and expected to vest, Weighted Average Remaining Contractual Term (in years) 0.0 0.0 0.0  
Restricted stock grants [Member]
       
Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Nonvested [Roll Forward]        
Outstanding, at beginning of year, Shares 70,595 54,729 116,860  
Granted, Shares 24,323 33,000 42,481  
Vested, Shares (7,787) (15,041) (104,112)  
Forfeited or expired, Shares (3,800) (2,093) (500)  
Outstanding, at end of year, Shares 83,331 70,595 54,729  
Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Nonvested, Weighted Average Grant Date Fair Value [Roll Forward]        
Outstanding, at beginning of year, Weighted Average Grant-Date Fair Value (in dollars per share) $ 18.44 $ 19.48 $ 26.25  
Granted, Weighted Average Granted-Date Fair Value (in dollars per share) $ 21.46 $ 20.63 $ 15.96  
Vested, Weighted Average Grant-Date Fair Value (in dollars per share) $ 17.56 $ 26.79 $ 25.69  
Forfeited or expired, Weighted Average Grant-Date Fair Value (in dollars per share) $ 16.44 $ 20.26 $ 10.78  
Outstanding, at end of year, Weighted Average Grant-Date Fair Value (in dollars per share) $ 19.49 $ 18.44 $ 19.48  
Employee Service Share-based Compensation, Nonvested Awards, Total Compensation Cost Not yet Recognized, Period for Recognition 2.45      
Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Vested in Period, Total Fair Value 0.2      
Restricted stock units [Member]
       
Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Nonvested [Roll Forward]        
Outstanding, at beginning of year, Shares 285,101 214,406 147,811  
Granted, Shares 125,589 140,357 83,780  
Forfeited or expired, Shares (10,483) (4,704) (8,289)  
Released, Shares (78,484) (64,958) (8,896)  
Outstanding, at end of year, Shares 321,723 285,101 214,406 147,811
Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Nonvested, Weighted Average Grant Date Fair Value [Roll Forward]        
Outstanding, at end of year (in dollars) $ 5.7 $ 6.9 $ 4.0 $ 2.0
Outstanding, at beginning of year, Weighted Average Remaining Contractual Term (in years) 1.4 1.5 1.2 1.7
Outstanding, at end of year, Weighted Average Remaining Contractual Term (in years) 1.4 1.5 1.2 1.7
Ending vested and expected to vest, Shares 308,645 269,679 201,266  
Ending vested and expected to vest, Aggregrate Intrinsic Value (in dollars) $ 5.4 $ 6.6 $ 3.9  
Ending vested and expected to vest, Weighted Average Remaining Contractual Term (in years) 1.4 1.5 1.2